434 related articles for article (PubMed ID: 23801135)
1. Castleman-Kojima disease (TAFRO syndrome) : a novel systemic inflammatory disease characterized by a constellation of symptoms, namely, thrombocytopenia, ascites (anasarca), microcytic anemia, myelofibrosis, renal dysfunction, and organomegaly : a status report and summary of Fukushima (6 June, 2012) and Nagoya meetings (22 September, 2012).
Kawabata H; Takai K; Kojima M; Nakamura N; Aoki S; Nakamura S; Kinoshita T; Masaki Y
J Clin Exp Hematop; 2013; 53(1):57-61. PubMed ID: 23801135
[TBL] [Abstract][Full Text] [Related]
2. Japanese variant of multicentric castleman's disease associated with serositis and thrombocytopenia--a report of two cases: is TAFRO syndrome (Castleman- Kojima disease) a distinct clinicopathological entity?
Masaki Y; Nakajima A; Iwao H; Kurose N; Sato T; Nakamura T; Miki M; Sakai T; Kawanami T; Sawaki T; Fujita Y; Tanaka M; Fukushima T; Okazaki T; Umehara H
J Clin Exp Hematop; 2013; 53(1):79-85. PubMed ID: 23801138
[TBL] [Abstract][Full Text] [Related]
3. Atypical hyaline vascular-type castleman's disease with thrombocytopenia, anasarca, fever, and systemic lymphadenopathy.
Iwaki N; Sato Y; Takata K; Kondo E; Ohno K; Takeuchi M; Orita Y; Nakao S; Yoshino T
J Clin Exp Hematop; 2013; 53(1):87-93. PubMed ID: 23801139
[TBL] [Abstract][Full Text] [Related]
4. A case of multicentric castleman's disease of mixed-type, which showed constellation of symptoms, i.e., thrombocytopenia, anasarca, anemia, fever, myelofibrosis, and lymphadenopathy.
Awano N; Inomata M; Sonoda Y; Kondoh K; Ono R; Moriya A; Ando T; Kumasaka T; Takemura T; Takeuchi K; Ikushima S
J Clin Exp Hematop; 2013; 53(1):101-5. PubMed ID: 23801141
[No Abstract] [Full Text] [Related]
5. Kidney biopsy findings in two patients with TAFRO syndrome: case presentations and review of the literature.
Zhou Q; Zhang Y; Zhou G; Zhu J
BMC Nephrol; 2020 Nov; 21(1):499. PubMed ID: 33225930
[TBL] [Abstract][Full Text] [Related]
6. Successful treatment of a patient with multicentric Castleman's disease who presented with thrombocytopenia, ascites, renal failure and myelofibrosis using tocilizumab, an anti-interleukin-6 receptor antibody.
Kawabata H; Kotani S; Matsumura Y; Kondo T; Katsurada T; Haga H; Kadowaki N; Takaori-Kondo A
Intern Med; 2013; 52(13):1503-7. PubMed ID: 23812199
[TBL] [Abstract][Full Text] [Related]
7. Validated international definition of the thrombocytopenia, anasarca, fever, reticulin fibrosis, renal insufficiency, and organomegaly clinical subtype (TAFRO) of idiopathic multicentric Castleman disease.
Nishimura Y; Fajgenbaum DC; Pierson SK; Iwaki N; Nishikori A; Kawano M; Nakamura N; Izutsu K; Takeuchi K; Nishimura MF; Maeda Y; Otsuka F; Yoshizaki K; Oksenhendler E; van Rhee F; Sato Y
Am J Hematol; 2021 Oct; 96(10):1241-1252. PubMed ID: 34265103
[TBL] [Abstract][Full Text] [Related]
8. TAFRO Syndrome.
Igawa T; Sato Y
Hematol Oncol Clin North Am; 2018 Feb; 32(1):107-118. PubMed ID: 29157612
[TBL] [Abstract][Full Text] [Related]
9. Hepatic Campylobacter jejuni infection in patients with Castleman-Kojima disease (idiopathic multicentric Castleman disease with thrombocytopenia, anasarca, fever, reticulin fibrosis, and organomegaly (TAFRO) syndrome).
Kageyama C; Igawa T; Gion Y; Iwaki N; Tabata T; Tanaka T; Kondo E; Sakai H; Tsuneyama K; Nomoto K; Noguchi H; Yoshino T; Yokota K; Sato Y
Pathol Int; 2019 Oct; 69(10):572-579. PubMed ID: 31631463
[TBL] [Abstract][Full Text] [Related]
10. Successful Treatment of TAFRO Syndrome, a Variant of Multicentric Castleman's Disease, with Cyclosporine A: Possible Pathogenetic Contribution of Interleukin-2.
Konishi Y; Takahashi S; Nishi K; Sakamaki T; Mitani S; Kaneko H; Mizutani C; Ukyo N; Hirata H; Tsudo M
Tohoku J Exp Med; 2015 Aug; 236(4):289-95. PubMed ID: 26250536
[TBL] [Abstract][Full Text] [Related]
11. The first report of adolescent TAFRO syndrome, a unique clinicopathologic variant of multicentric Castleman's disease.
Kubokawa I; Yachie A; Hayakawa A; Hirase S; Yamamoto N; Mori T; Yanai T; Takeshima Y; Kyo E; Kageyama G; Nagai H; Uehara K; Kojima M; Iijima K
BMC Pediatr; 2014 Jun; 14():139. PubMed ID: 24890946
[TBL] [Abstract][Full Text] [Related]
12. Successful treatment of a Caucasian case of multifocal Castleman's disease with TAFRO syndrome with a pathophysiology targeted therapy - a case report.
Tedesco S; Postacchini L; Manfredi L; Goteri G; Luchetti MM; Festa A; Gabrielli A; Pomponio G
Exp Hematol Oncol; 2015; 4(1):3. PubMed ID: 25671135
[TBL] [Abstract][Full Text] [Related]
13. Complete resolution of TAFRO syndrome (thrombocytopenia, anasarca, fever, reticulin fibrosis and organomegaly) after immunosuppressive therapies using corticosteroids and cyclosporin A : a case report.
Inoue M; Ankou M; Hua J; Iwaki Y; Hagihara M; Ota Y
J Clin Exp Hematop; 2013; 53(1):95-9. PubMed ID: 23801140
[TBL] [Abstract][Full Text] [Related]
14. The first case of thrombocytopenia, anasarca, fever, renal impairment or reticulin fibrosis, and organomegaly (TAFRO) syndrome with unilateral adrenal necrosis: a case report.
Fujiwara Y; Ito K; Takamura A; Nagata K
J Med Case Rep; 2018 Oct; 12(1):295. PubMed ID: 30293532
[TBL] [Abstract][Full Text] [Related]
15. TAFRO syndrome: 2 cases and review of the literature.
Kawashima M; Usui T; Okada H; Mori I; Yamauchi M; Ikeda T; Kajita K; Kito Y; Miyazaki T; Fujioka K; Ishizuka T; Morita H
Mod Rheumatol; 2017 Nov; 27(6):1093-1097. PubMed ID: 26052800
[TBL] [Abstract][Full Text] [Related]
16. Castleman's disease with TAFRO syndrome: a case report from Syria.
Alhoulaiby S; Ahmad B; Alrstom A; Kudsi M
Oxf Med Case Reports; 2017 Jun; 2017(6):omx021. PubMed ID: 28580156
[TBL] [Abstract][Full Text] [Related]
17. TAFRO syndrome successfully treated with tocilizumab: A case report and systematic review.
Sakai K; Maeda T; Kuriyama A; Shimada N; Notohara K; Ueda Y
Mod Rheumatol; 2018 May; 28(3):564-569. PubMed ID: 26886414
[TBL] [Abstract][Full Text] [Related]
18. Renal histology in a patient with TAFRO syndrome: a case report.
Mizuno H; Sekine A; Oguro M; Oshima Y; Kawada M; Sumida K; Yamanouchi M; Hayami N; Suwabe T; Hiramatsu R; Hasegawa E; Hoshino J; Sawa N; Fujii T; Takaichi K; Ohashi K; Ubara Y
Hum Pathol; 2018 Dec; 82():258-263. PubMed ID: 29626596
[TBL] [Abstract][Full Text] [Related]
19. A comparison of TAFRO syndrome between Japanese and non-Japanese cases: a case report and literature review.
Coutier F; Meaux Ruault N; Crepin T; Bouiller K; Gil H; Humbert S; Bedgedjian I; Magy-Bertrand N
Ann Hematol; 2018 Mar; 97(3):401-407. PubMed ID: 28956126
[TBL] [Abstract][Full Text] [Related]
20. TAFRO syndrome: New subtype of idiopathic multicentric Castleman disease.
Srkalovic G; Marijanovic I; Srkalovic MB; Fajgenbaum DC
Bosn J Basic Med Sci; 2017 May; 17(2):81-84. PubMed ID: 28135567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
